rHuEPO treatment improves brain and cognitive function of anemic dialysis patients.
about
Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort studyHigher doses of erythropoietin-stimulating agents and hyporesponsiveness to their effects are associated with increased mortality among prevalent hemodialysis patients.The hematopoietic cytokine granulocyte-macrophage colony stimulating factor is important for cognitive functions.Multivariate regression analyses of data from a randomised, double-blind, placebo-controlled study confirm quality of life benefit of epoetin alfa in patients receiving non-platinum chemotherapyPrevalence and correlates of cognitive impairment in hemodialysis patients: the Frequent Hemodialysis Network trials.Should hemoglobin be normalized in patients with chronic kidney disease?Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study.Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies.Cerebral microbleeds and cognitive decline in a hemodialysis patient: Case report and review of literatureClinical predictors of neurocognitive deficits in children with chronic kidney disease.The nervous system and chronic kidney disease in childrenClinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP Study.Anemia and risk for cognitive decline in chronic kidney disease."Out of Sight, Out of Mind": The Failed Renal Allograft as a Cause of ESA Resistance.Hyponatremia and Cognitive Impairment in Patients Treated with Peritoneal DialysisPatients with Complex Chronic Diseases: perspectives on supporting self-management.Association between mild anemia and executive function impairment in community-dwelling older women: The Women's Health and Aging Study II.Relationship between cognitive impairment and depression in dialysis patientsPredialysis chronic kidney disease: evaluation of quality of life in clinic patients receiving comprehensive anemia care.Nervous system autoantibodies and vitamin D receptor gene polymorphisms in hemodialysis patients.Iron status and neuropsychological consequences in women of reproductive age: what do we know and where are we headed?Renal anemia: from incurable to curable.Midlife iron status is inversely associated with subsequent cognitive performance, particularly in perimenopausal women.Prevalence and management of anemia in pre-dialysis Malaysian patients: A hospital-based study.CRIT-LINE: a noninvasive tool to monitor hemoglobin levels in pediatric hemodialysis patients.Memory performance in adequately dialyzed patients with end-stage renal disease: is there an association with coronary artery bypass grafting?Erythropoietin treatment and plasma levels of corticotropin-releasing hormone, delta sleep-inducing peptide and opioid peptides in hemodialysis patients.De novo weekly and biweekly darbepoetin alfa dosing in pediatric patients with chronic kidney disease.Well-preserved cholinergic neuronal activity in the brain cortex of the severely uremic rats.Subcortical cognitive impairment in dialysis patients.Cerebral blood flow changes in hemodialysis and peritoneal dialysis patients: an arterial-spin labeling MR imaging.Is there differences in cognitive and motor functioning between hemodialysis and peritoneal dialysis patients?Risk factors for cognitive dysfunction in CKD and hypertensive subjects.Memory and executive functions in pediatric chronic kidney disease.
P2860
Q30419884-CCCDCA68-A33B-473B-9A90-CFC0995659DAQ30456721-25308F84-4C92-49DD-BA96-8A4F874B91B1Q30463376-78111349-D705-43E1-9422-C2ACA04439AAQ30749943-A390E8FC-5B78-4E85-AA4D-1C87AB7E406EQ34075467-24EE1466-5379-429B-955E-F924C853633BQ34549905-CA718865-8772-4168-95D2-5DCF3FD62451Q34639546-4B09FB2B-94BE-44EA-A9A8-2CE6829AEF8EQ35021612-E778CEF7-A48D-4B00-81A8-BC0F955425D2Q35133379-B4EC32CB-3C2B-449B-AC4E-499EA268335DQ35650605-7719212A-17E2-439A-8587-FC3C608B4391Q35819555-3E5704ED-EA65-4AD8-9AD6-1EFFD11088BCQ35859784-324ADC00-04F7-48AE-9CBC-7C2D3F124A4CQ35907946-C31260C2-5249-4C39-9C8F-193EF6685C4CQ36029516-489767D7-5E62-4BC9-91A5-6100C3A347D7Q36123623-702A69E8-D484-40DB-8F2E-070F40B4D471Q36293451-8D928DF4-27DC-4568-8E77-8A4CE86C3EBAQ37156454-3255F531-0A31-4916-A8B6-D2B2A46074D0Q37259546-0F71FCCF-F58C-48CD-B9B7-BC2A270EFD67Q37292588-0A3C9AFE-8FF2-4385-AB2C-EEC5C5C062C6Q37572239-3DFA5345-AE0B-4B13-9B26-06FC34E81404Q37846401-285DF08F-74A6-4D8F-AFDE-66D98FE94C23Q38123955-E136C24F-E768-445A-8A19-43E8090E938BQ38443623-684A013D-B194-4B10-BC11-C662382A1750Q40418454-F21FE97B-3BD5-4E09-9B09-A02E99D0C23FQ41100094-929052EC-6A8E-4F51-A037-B9725FA7F39FQ43054117-0A2C7237-1790-45BD-980F-6A3C9409260EQ43525133-90F40645-68C6-45BC-94AE-7231C22047DFQ45065477-070C9508-1372-40FD-A6D3-F488B4F5F4E5Q48093309-461B1308-77AA-41DE-8CC5-C70E1348EB33Q48132639-FA97DBA9-E4C9-41D5-B6BA-84BE7C19A06CQ48743728-3B293333-DAC1-4E12-A5F7-9D23AD8ACC48Q51005135-8ED2E3CE-4D7E-405D-8B3C-69F92A03AC2FQ51026220-627C8B55-65AD-40B8-ACB6-D6C0E5E262FBQ51979632-57BF84F4-02E0-4542-8D35-A8EAA891B3C2
P2860
rHuEPO treatment improves brain and cognitive function of anemic dialysis patients.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
rHuEPO treatment improves brain and cognitive function of anemic dialysis patients.
@en
type
label
rHuEPO treatment improves brain and cognitive function of anemic dialysis patients.
@en
prefLabel
rHuEPO treatment improves brain and cognitive function of anemic dialysis patients.
@en
P2093
P356
P1433
P1476
rHuEPO treatment improves brain and cognitive function of anemic dialysis patients.
@en
P2093
Nissenson AR
Schweitzer SV
P2888
P304
P356
10.1038/KI.1991.20
P407
P577
1991-01-01T00:00:00Z